Reversal of pipecuronium-induced moderate neuromuscular block with sugammadex in the presence of a sevoflurane anesthetic: A randomized trial

Anesthesia and Analgesia

Volumn 121, Issue 2, 2015, Pages 373-380

  Tassonyi, Edömér ^a   Pongrácz, Adrienn ^a   Nemes, Réka ^a   Asztalos, László ^a   Lengyel, Szabolcs ^b   Fülesdi, Béla ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; PIPECURONIUM; PROPOFOL; SEVOFLURANE; SUGAMMADEX; ANTIDOTE; ETHER DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; INHALATION ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT;

ACCELEROMYOGRAPHY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; MIDDLE AGED; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; ADVERSE EFFECTS; AGED; ANESTHETIC RECOVERY; CHEMICALLY INDUCED; CONVALESCENCE; DRUG EFFECTS; HUNGARY; NEUROMUSCULAR JUNCTION DISEASES; NEUROMUSCULAR SYNAPSE; PATHOPHYSIOLOGY; PROCEDURES; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANTIDOTES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; HUNGARY; MALE; METHYL ETHERS; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR JUNCTION DISEASES; NEUROMUSCULAR MONITORING; PIPECURONIUM; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84937920574     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000766     Document Type: Article

References (41)

1. Tuba Z, Synthesis of 2 beta,16 beta-bis-(4′-dimethyl-1′-piperazino)-3 alpha,17 beta-diacetoxy-5 alpha-androstane dibromide and related compounds. Arzneimittelforschung 1980 30 342 6
2. Baird WL, Reid AM, The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. Br J Anaesth 1967 39 775 80
3. Boros M, Szenohradszky J, Marosi G, Tóth I, Comparative clinical study of pipecurium bromide and pancuronium bromide. Arzneimittelforschung 1980 30 389 93
4. Tassonyi E, Neidhart P, Pittet JF, Morel DR, Gemperle M, Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology 1988 69 793 6
5. Futo J, Kupferberg JP, Moss J, Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants. Biochem Pharmacol 1990 39 415 20
6. Azad SS, Larijani GE, Goldberg ME, Beach CA, Marr AT, Seltzer JL, A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia. J Clin Pharmacol 1989 29 657 9
7. Pittet JF, Tassonyi E, Morel DR, Gemperle G, Richter M, Rouge JC, Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children. Anesthesiology 1989 71 210 3
8. Larijani GE, Bartkowski RR, Azad SS, Seltzer JL, Weinberger MJ, Beach CA, Goldberg ME, Clinical pharmacology of pipecuronium bromide. Anesth Analg 1989 68 734 9
9. Foldes FF, Nagashima H, Nguyen HD, Duncalf D, Goldiner PL, Neuromuscular and cardiovascular effects of pipecuronium. Can J Anaesth 1990 37 549 55
10. Wierda JM, Richardson FJ, Agoston S, Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl. Anesth Analg 1989 68 208 13
11. Pittet JF, Tassonyi E, Schopfer C, Morel DR, Leemann P, Mentha G, Le Coultre C, Steinig DA, Benakis A, Dose requirements and plasma concentrations of pipecuronium during bilateral renal exclusion and orthotopic liver transplantation in pigs. Br J Anaesth 1990 65 779 85
12. Srivastava A, Hunter JM, Reversal of neuromuscular block. Br J Anaesth 2009 103 115 29
13. Pongrácz A, Szatmári S, Nemes R, Fülesdi B, Tassonyi E, Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology 2013 119 36 42
14. Kirkegaard H, Heier T, Caldwell JE, Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002 96 45 50
15. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ, A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002 41 266 70
16. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I, Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007 106 283 8
17. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC, Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998 87 936 40
18. Claudius C, Skovgaard LT, Viby-Mogensen J, Is the performance of acceleromyography improved with preload and normalization? A comparison with mechanomyography. Anesthesiology 2009 110 1261 70
19. Ali HH, Criteria of adequate clinical recovery from neuromuscular block. Anesthesiology 2003 98 1278 80
20. Stanley JC, Mirakhur RK, Bell PF, Sharpe TD, Clarke RS, Neuromuscular effects of pipecuronium bromide. Eur J Anaesthesiol 1991 8 151 6
21. Schulz KF, Grimes DA, Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002 359 515 9
22. Suzuki T, A train-of-four ratio of 0.9 may not certify adequate recovery after sugammadex. Acta Anaesthesiol Scand 2011 55 368 9
23. Gijsenbergh F, Ramael S, Houwing N, van Iersel T, First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005 103 695 703
24. Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, van Duijnhoven W, Heeringa M, Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Br J Anaesth 2010 105 610 9
25. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J, 8th International Neuromuscular Meeting 8th International Neuromuscular Meeting Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007 51 789 808
26. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T, Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004 100 1119 24
27. Jonsson M, Gurley D, Dabrowski M, Larsson O, Johnson EC, Eriksson LI, Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade. Anesthesiology 2006 105 521 33
28. Kopman AF, Klewicka MM, Neuman GG, The relationship between acceleromyographic train-of-four fade and single twitch depression. Anesthesiology 2002 96 583 7
29. Staals LM, Driessen JJ, Van Egmond J, De Boer HD, Klimek M, Flockton EA, Snoeck MM, Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex. Acta Anaesthesiol Scand 2011 55 700 7
30. Cedborg AI, Sundman E, Bodén K, Hedström HW, Kuylenstierna R, Ekberg O, Eriksson LI, Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology 2014 120 312 25
31. Debaene B, Plaud B, Dilly MP, Donati F, Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003 98 1042 8
32. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear T, Vender JS, Gray J, Landry E, Postoperative residual neuromuscular blockade is associated with impaired clinical recovery. Anesth Analg 2013 117 133 41
33. Morita T, Tsukagoshi H, Sugaya T, Saito S, Sato H, Fujita T, Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. Anesth Analg 1995 80 1175 80
34. Nakao Y, Ohno M, Imai M, Kemmotsu O, Neuromuscular effects of pipecuronium during sevoflurane anesthesia compared with isoflurane and enflurane anesthesia. J Anesth 1993 7 405 10
35. Bevan DR, Smith CE, Donati F, Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988 69 272 6
36. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ, Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997 41 1095 103
37. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, Ehrenfeld JM, Martinez EA, Kurth T, Eikermann M, Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012 345 e6329
38. Kim KS, Lew SH, Cho HY, Cheong MA, Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg 2002 95 1656 60
39. Esteves S, Martins M, Barros F, Barros F, Canas M, Vitor P, Seabra M, Castro MM, Bastardo I, Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. Eur J Anaesthesiol 2013 30 243 9
40. Eriksson LI, Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003 98 1037 9
41. Plaud B, Debaene B, Donati F, Marty J, Residual paralysis after emergence from anesthesia. Anesthesiology 2010 112 1013 22